NON-SMALL CELL CARCINOMA
Clinical trials for NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Liver radiation boosts immunotherapy in advanced lung cancer trial
Disease control Recruiting nowThis study tests whether adding a precise, high-dose radiation treatment to the liver (L-SABR) to standard immunotherapy can help people with stage IV non-small cell lung cancer that has spread to the liver. About 68 adults will be randomly assigned to receive either standard dru…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:41 UTC
-
New hope for tough lung cancer: experimental drug faces off against standard chemo
Disease control Recruiting nowThis study tests a new drug, PF-08046054, against the standard chemo docetaxel in people with advanced non-small cell lung cancer that has PD-L1 protein and has stopped responding to prior treatments. About 680 adults will be randomly assigned to one of the two drugs, given as IV…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 05:36 UTC
-
New combo therapy hopes to shrink tough lung tumors
Disease control Recruiting nowThis early-phase study tests whether adding the experimental drug binimetinib to the immunotherapy pembrolizumab can help shrink tumors in people with advanced non-small cell lung cancer. About 40 participants whose cancer has a specific marker (PD-L1 ≥50%) will receive the combi…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New pill targets Hard-to-Treat cancers with specific gene mutation
Disease control Recruiting nowThis early-phase study tests a new oral drug, DO-2, in adults with advanced solid tumors (like lung cancer) that have a specific MET gene change and no standard treatment options left. The main goal is to check the drug's safety and find the right dose. About 55 participants will…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: DeuterOncology • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
Step up recovery: telecoaching boosts activity after lung cancer surgery
Symptom relief Recruiting nowThis study tests a 12-week home-based physical activity coaching program for people who had surgery for early-stage lung cancer. Participants wear a Fitbit and get personalized step goals and coach support via a smartphone app. The goal is to see if this program helps patients be…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated May 26, 2026 05:28 UTC